Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RISCHIN, D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 43

  • Page / 2
Export

Selection :

  • and

Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum(II)RISCHIN, D; LING, V.British journal of cancer. 1996, Vol 74, Num 4, pp 590-596, issn 0007-0920Article

A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patientsPOOLE, S. G; DOOLEY, M. J; RISCHIN, D et al.Annals of oncology. 2002, Vol 13, Num 6, pp 949-955, issn 0923-7534Article

Dosing of cytotoxic chemotherapy: impact of renal function estimates on doseDOOLEY, M. J; POOLE, S. G; RISCHIN, D et al.Annals of oncology. 2013, Vol 24, Num 11, pp 2746-2752, issn 0923-7534, 7 p.Article

Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patientsDOOLEY, M. J; SINGH, S; RISCHIN, D et al.British journal of cancer. 2004, Vol 90, Num 5, pp 991-995, issn 0007-0920, 5 p.Article

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumorsHOLDEN, S. N; ECKHARDT, S. G; BASSER, R et al.Annals of oncology. 2005, Vol 16, Num 8, pp 1391-1397, issn 0923-7534, 7 p.Article

Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neckCLARKE, S. J; ZALCBERG, J; OLVER, I et al.Annals of oncology. 2000, Vol 11, Num 2, pp 239-241, issn 0923-7534Article

Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemiaHU, X. F; SLATER, A; KANTHARIDIS, P et al.Blood. 1999, Vol 93, Num 12, pp 4086-4095, issn 0006-4971Article

Ifosfamide in combination with paclitaxel or doxorubicin : regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerPRINCE, H. M; GARDYN, J; JANUSZEWICZ, E. H et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 5, pp 427-435, issn 0268-3369Article

Phase II study of Docetaxel and cisplatin in advanced non-small-cell lung CancerZALCBERG, J; MILLWARD, M; JAMES, R et al.Journal of clinical oncology. 1998, Vol 16, Num 5, pp 1948-1953, issn 0732-183XArticle

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancerSOLOMON, B; BALL, D. L; RYAN, G et al.Lung cancer. 2003, Vol 41, Num 3, pp 353-361, issn 0169-5002, 9 p.Article

A phase II trial of ZD0473 in platinum-pretreated ovarian cancerGORE, M. E; ATKINSON, R. J; THOMAS, H et al.European journal of cancer (1990). 2002, Vol 38, Num 18, pp 2416-2420, issn 0959-8049, 5 p.Article

A phase II trial of paclitaxel and epirubicin in advanced breast cancerRISCHIN, D; SMITH, J; MILLWARD, M et al.British journal of cancer. 2000, Vol 83, Num 4, pp 438-442, issn 0007-0920Article

Docetaxel effectively mobilizes peripheral blood CD34+ cellsPRINCE, H. M; TONER, G. C; WOLF, M et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 5, pp 483-487, issn 0268-3369Article

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer : Results of a phase I studyPRINCE, H. M; MILLWARD, M. J; JANUSZEWICZ, E. H et al.Annals of oncology. 1999, Vol 10, Num 4, pp 479-481, issn 0923-7534Article

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly vinorelbine and cisplatin in patients with locally advanced and metastatic NSCLCMICHAEL, M; WIRTH, A; BALL, D. L et al.British journal of cancer. 2005, Vol 93, Num 6, pp 652-661, issn 0007-0920, 10 p.Article

Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rateDOOLEY, M. J; POOLE, S. G; RISCHIN, D et al.European journal of cancer (1990). 2002, Vol 38, Num 1, pp 44-51, issn 0959-8049Article

Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: A case report and review of the literatureMA, B; CORRY, J; RISCHIN, D et al.Annals of oncology. 2001, Vol 12, Num 7, pp 1015-1017, issn 0923-7534Article

A phase I trial of docetaxel and gemcitabine in patients with advanced cancerRISCHIN, D; BOYER, M; SMITH, J et al.Annals of oncology. 2000, Vol 11, Num 4, pp 421-426, issn 0923-7534Article

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerMILLWARD, M. J; ZALCBERG, J; BRUNO, R et al.Journal of clinical oncology. 1997, Vol 15, Num 2, pp 750-758, issn 0732-183XArticle

Carboplastin dosing based on measurement of renal function : experience at the Peter MacCallum Cancer InstituteMILLWARD, M. J; WEBSTER, L. K; TONER, G. C et al.Australian and New Zealand journal of medicine. 1996, Vol 26, Num 3, pp 372-379, issn 0004-8291Article

Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxelJENNENS, R; RISCHIN, D; YUEN, K et al.Gynecologic oncology (Print). 2003, Vol 91, Num 1, pp 190-193, issn 0090-8258, 4 p.Article

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopeniaROSENTHAL, M. A; RISCHIN, D; MCARTHUR, G et al.Annals of oncology. 2002, Vol 13, Num 5, pp 770-776, issn 0923-7534Article

Phase I trial of cremophor EL with bolus doxorubicinMILLWARD, M. J; WEBSTER, L. K; RISCHIN, D et al.Clinical cancer research. 1998, Vol 4, Num 10, pp 2321-2329, issn 1078-0432Article

A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancerRISCHIN, D; BISHOP, J. F; OLVER, I. N et al.American journal of clinical oncology. 1992, Vol 15, Num 5, pp 392-394, issn 0277-3732Article

A randomised trial of dexamethasone, lorazepan and prochlorperazine for emesis in patients receiving chemotherapyBISHOP, J. F; MATTHEWS, J. P; WOLF, M. M et al.European journal of cancer (1990). 1992, Vol 28, Num 1, pp 47-50, issn 0959-8049Conference Paper

  • Page / 2